HomeTagsMirati Therapeutics

Mirati Therapeutics

Biotechnology

Journal of Clinical Oncology Publishes Rapid Communication Featuring Updated Clinical Data for Adagrasib as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors

PR Newswire - April 28, 2023

Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...

Healthcare

Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

PR Newswire - May 17, 2022

Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced the appointment of Laurie Stelzer as the Company's Chief Financial Officer (CFO) effective May 16,...